BioDataSci, Inc. was founded in 2017 by Jeremy Chambers, M.Sc. SE, CMU. He formerly consulted over a decade in Silicon Valley before moving East to write NGS bioinformatics software for 454 Life Sciences (acquired by Roche), build big-genomic-data POCs for Platform Computing (acquired by IBM), and lead hybrid-cloud, data architecture, and data science at Biogen. 

​

Most recent project: IT strategy and implementation of cloud microservices for the world's first RNA/DNA enzymatic-synthesis design platform.

​

BioDataSci provides consulting services to biotech startups and major pharma.  Our clients (both in the US and abroad) typically need a mix of:

 

• Broad and deep biotech domain knowledge and experience

• Visioneering with Product Scientists to define MVP around their core ideas
• Information Architecture and Data Governance based on FAIR principals
• Strategy and derived Architecture Runway to lead Engineering
• POCs to mitigate risk and substantiate greater investment
• Multiparty data and analytics/ML/AI planning and coordination
• Hybrid cloud, multilayer data and compute architectures with self-service capabilities
• Data Science platform ecosystems, pipeline and model prototyping

• Software engineering with advanced CI/CD and testing capabilities